Progesterone Price Chart, Trend, Index, News, Demand, and Forecast
Progesterone Price Chart Analysis: Regional Trends and Market Outlook for Q2 2025
The global Progesterone market witnessed a mild yet notable upward trend during the second quarter of 2025, supported by tightening supply fundamentals and renewed demand from the pharmaceutical sector. As reflected in the Progesterone Price Chart, all major regions — North America, Asia-Pacific (APAC), and Europe — recorded positive quarter-over-quarter (QoQ) movements, albeit modest in magnitude.
This article provides a comprehensive breakdown of Progesterone price trends, regional drivers, and market dynamics shaping the Progesterone Price Chart during Q2 2025.
Overview of the Global Progesterone Market in Q2 2025
During Q2 2025, the Progesterone market demonstrated a stable upward momentum across major geographies. While the gains were limited compared to earlier volatility, the recovery highlighted improving downstream demand from the pharmaceutical, veterinary, and personal care sectors.
In all three key markets — North America, APAC, and Europe — spot price indices moved upward between 0.1% and 0.14% on a quarter-over-quarter basis. The market’s firm tone reflected tightening raw material supply chains, moderate production costs, and stable consumption in end-user industries.
North America: Progesterone Prices Strengthen After a Slow Start
Price Performance and Quarterly Overview
According to the Progesterone Price Chart for North America, Q2 2025 witnessed a mildly upward trend, averaging a quarter-over-quarter increase of approximately 0.12%. Spot prices closed June 2025 at around USD 172,688 per metric ton, signaling a gradual firming after a subdued start to the quarter.
In April 2025, prices began the quarter on a weaker note, influenced by lingering inventory from the previous quarter and moderate demand from pharmaceutical formulators. However, as May and June progressed, a combination of supply adjustments, rising raw material costs, and steady API (Active Pharmaceutical Ingredient) demand helped prices rebound modestly.
Get Real time Prices for Progesterone: https://www.chemanalyst.com/Pricing-data/progesterone-1648
Market Drivers and Supply Dynamics
A few key factors shaped North America’s Progesterone price trajectory in Q2 2025:
- Pharmaceutical Sector Demand:
The resurgence in production of hormone-based therapeutics, especially for fertility treatments, hormone replacement therapy (HRT), and menstrual disorder management, sustained domestic consumption levels. U.S.-based API manufacturers and compounding pharmacies reported steady procurement activities throughout May and June. - Supply Chain and Feedstock Availability:
While North American producers maintained consistent output, occasional supply constraints in steroidal intermediates led to slight upward pricing pressures. Feedstock costs tied to raw plant extracts and synthesis materials also ticked higher, aligning with broader chemical market trends. - Import and Export Movements:
Limited imports from Asia, particularly China and India, due to higher freight rates and currency fluctuations, further supported local prices. Export-oriented suppliers in the U.S. and Canada benefitted from a weaker dollar during mid-Q2, enhancing global competitiveness.
Outlook and Future Trends
Looking ahead, the Progesterone Price Chart for North America indicates continued firmness through Q3 2025. With sustained pharmaceutical demand and balanced supply levels, prices are expected to hover near current averages with limited volatility. Any disruptions in raw material procurement or shifts in API production costs could, however, trigger short-term adjustments.
Asia-Pacific (APAC): Gradual Recovery After Early Quarter Decline
Price Movement Overview
The APAC Progesterone Price Chart for Q2 2025 reflected a general upward trajectory, marking an average quarter-over-quarter increase of around 0.1%. By June 2025, spot prices closed near USD 172,500 per metric ton, recovering from earlier declines in export quotations during April.
Early in the quarter, exporters in China and India faced softer price realizations due to sluggish overseas demand and inventory overhangs. However, by late May, a rebound in international pharmaceutical procurement and modest local restocking helped lift market sentiment.
Key Influencing Factors
- Export Market Rebound:
The mid-quarter revival in Chinese and Indian exports played a key role in shaping regional price movement. Global buyers resumed inquiries, particularly from Europe and North America, helping stabilize export values. - Raw Material and Production Costs:
Rising costs for plant-based sterols and synthetic precursors added to the production cost base. Additionally, stricter environmental regulations in China slightly constrained production capacity, adding to market tightness. - Domestic Demand from Pharmaceutical Manufacturing:
In countries like India, South Korea, and Japan, local pharmaceutical output remained resilient. The progesterone API was in steady demand for contraceptive formulations, veterinary drugs, and hormone therapy products, further supporting regional consumption.
Country-Specific Highlights
- China: Prices recovered gradually after April’s dip, aided by export rebound and limited producer inventories.
- India: Strong domestic pharmaceutical demand and steady exports to Europe and the U.S. underpinned pricing stability.
- Japan and South Korea: High-quality progesterone imports from Europe saw moderate price growth due to currency adjustments and improved pharma-sector demand.
Outlook for the APAC Market
The Progesterone Price Chart for APAC suggests a cautiously optimistic trajectory going into Q3 2025. With steady domestic consumption and balanced exports, prices are projected to maintain current levels, with possible marginal gains if raw material prices rise further or regulatory bottlenecks intensify in China.
Europe: Upward Momentum Driven by Tight Supply and Firm Demand
Price Index and Quarterly Summary
The European Progesterone Price Chart revealed an upward trend during Q2 2025, with an average quarter-over-quarter growth of approximately 0.14%. Spot prices concluded June 2025 near €172,610 per metric ton, marking one of the strongest regional performances among major markets.
Throughout the quarter, European markets faced tight supply conditions, stemming from reduced imports from APAC and limited domestic production. Concurrently, pharmaceutical formulation activity in key countries like Germany, France, and Switzerland remained robust, supporting consistent demand for progesterone as an essential API.
Key Market Influences
- Tight Supply Chains:
Several European producers operated at controlled production rates due to feedstock constraints and high energy costs, particularly during April and May. The region’s dependency on imports from Asia further intensified supply tightness. - Steady Pharmaceutical Demand:
The pharma and biotech industries across Western Europe maintained high production levels, driven by steady demand for hormonal therapies, especially in the women’s health and fertility treatment segments. This sustained offtake kept prices on a modest upward slope. - Currency and Trade Dynamics:
The Euro’s relative strength against the dollar partially offset input cost pressures for some importers, but the overall tightness in supply outweighed currency advantages. Regulatory compliance costs also added to producer overheads.
Regional Highlights
- Germany: Served as the core market with stable API production and strong end-user demand.
- France and Italy: Pharmaceutical manufacturing activity remained high, boosting progesterone consumption.
- UK and Spain: Moderate price gains observed due to limited import volumes and steady local consumption.
🌐 🔗 Track real time Progesterone prices and market trends on ChemAnalyst: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Progesterone
Forward Outlook
The Progesterone Price Chart in Europe points to continued firmness into Q3 2025, with limited downside risk unless supply significantly improves. Rising energy and raw material costs may sustain moderate upward pressure through the next quarter.
Comparative Regional Analysis: Global Progesterone Price Chart Insights
Region | Average QoQ Change (Q2 2025) | June 2025 Closing Price | Market Trend |
North America | +0.12% | USD 172,688/mt | Mildly upward |
Asia-Pacific (APAC) | +0.10% | USD 172,500/mt | Gradual recovery |
Europe | +0.14% | €172,610/mt | Firm upward |
From the Progesterone Price Chart, it’s evident that Europe led the price growth momentum in Q2 2025 due to supply tightness, while North America and APAC showed moderate but stable improvements.
The convergence in price levels across regions underscores the global interconnectedness of progesterone supply chains, where fluctuations in feedstock availability or regulatory environments in one region can ripple through international markets.
Key Market Drivers Influencing the Global Progesterone Price Chart
- Pharmaceutical Demand Stability:
Progesterone remains a critical API for hormone-based therapies and reproductive health treatments, ensuring consistent baseline demand across global markets. - Raw Material and Production Costs:
The cost of precursors such as plant sterols, diosgenin, and steroidal intermediates continues to influence production economics. Rising extraction and synthesis costs have directly impacted progesterone pricing. - Regulatory and Environmental Constraints:
Stricter environmental policies in manufacturing hubs like China have constrained output capacity, indirectly supporting global price resilience. - Trade and Currency Dynamics:
Exchange rate fluctuations and freight rate volatility continue to impact trade competitiveness, especially between Asia and Europe. - Energy Prices and Inflationary Pressures:
Europe’s energy-intensive production landscape and inflationary trends in logistics contribute to price variation across regions.
Market Outlook: What to Expect for Q3 2025
Based on the current Progesterone Price Chart and Q2 performance trends, the global market outlook for Q3 2025 remains cautiously optimistic. Prices are likely to remain stable to slightly higher, supported by:
- Persistent pharmaceutical demand
- Balanced inventory levels
- Gradual stabilization of supply chains
However, uncertainties such as feedstock availability, energy cost volatility, and regulatory developments in Asia could introduce mild price fluctuations.
Conclusion
The Progesterone Price Chart for Q2 2025 highlights a synchronized but modest upward momentum across global markets. With North America showing gradual strengthening, APAC rebounding from early softness, and Europe maintaining firm pricing on tight supply, the overall market demonstrated resilience.
Looking forward, as demand for hormonal APIs continues to rise, and sustainability regulations reshape production economics, progesterone prices are expected to sustain a steady-to-firm trend through the remainder of 2025.
Investors, buyers, and manufacturers should continue monitoring regional supply dynamics, feedstock costs, and trade flows, as these factors will remain crucial in determining the future trajectory of the global Progesterone Price Chart.
Contact Us:
ChemAnalyst
GmbH - S-01, 2.floor, Subbelrather Straße,
15a Cologne, 50823, Germany
Call: +49-221-6505-8833
Email: sales@chemanalyst.com
Website: https://www.chemanalyst.com/
Comments
Post a Comment